Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Haddag

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diagnostic and Interventional Imaging|October 7, 2015
Breast pain and imagingC Balleyguier, J Arfi-Rouche, L Haddag, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 20, 2023
Intraoperative motive for incomplete resection in primary retroperitoneal sarcomaB Acidi, M Faron, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2022
Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpressionC Ngo, T Grinda, A Boilève, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trialA Le Cesne, J-Y Blay, D Cupissol, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diagnostic and Interventional Imaging|October 7, 2015
Breast pain and imagingC Balleyguier, J Arfi-Rouche, L Haddag, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 20, 2023
Intraoperative motive for incomplete resection in primary retroperitoneal sarcomaB Acidi, M Faron, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2022
Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpressionC Ngo, T Grinda, A Boilève, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trialA Le Cesne, J-Y Blay, D Cupissol, et al.
Pageof 1